Abstract:Fengxia Lin, 1, * Yiying Yang, 2, * Shanyin Wei, 1 Xiaojing Huang, 1 Zhijian Peng, 1 Xiao Ke, 3 Zhicong Zeng, 1 Yinzhi Song 1 1 Department of Cardiology, Shenzhen Bao'an Traditional Chinese Medicine Hospital Group, The Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen 518133, People's Republic of China; 2 Department of Cardiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, People's Republic of China; 3 Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, (Shenzhen Sun Yat-sen Cardiovascular Hospital), Shenzhen 518057, People's Republic of China *These authors contributed equally to this work Correspondence: Zhicong Zeng; Yinzhi Song Email 2436225392@qq.com; songyinzhi@126.com Purpose: Dysfunction of endothelial cells plays a key role in the pathogenesis of diabetic atherosclerosis. High glucose (HG) has been found as a key factor in the progression of diabetic complications, including atherosclerosis. PI3K/Akt/eNOS signaling pathway has been shown to involve in HG-induced vascular injuries. Hydrogen sulfide (H 2 S) has been found to exhibit protective effects on HG-induced vascular injuries. Moreover, H 2 S activates PI3K/Akt/eNOS pathway in endothelial cells. Thus, the present study aimed to determine if H 2 S exerts protective effects against HG-induced injuries of human umbilical vein endothelial cells (HUVECs) via activating PI3K/Akt/eNOS signaling. Materials and Methods: The endothelial protective effects of H 2 S were evaluated and compared to the controlled groups. Cell viability, cell migration and tube formation were determined by in vitro functional assays; protein levels were evaluated by Western blot assay and ELISA; cell apoptosis was determined by Hoechst 33258 nuclear staining; Reactive oxygen species (ROS) production was evaluated by the ROS detection kit. Results: HG treatment significantly inhibited PI3K/Akt/eNOS signaling in HUVECs, which was partially reversed by the H2S treatment. HG treatment inhibited cell viability of HUVECs, which were markedly prevented by H 2 S or PI3K agonist Y-P 740. HG treatment also induced HUVEC cell apoptosis by increasing the protein levels of cleaved caspase 3, Bax and Bcl-2, which were significantly attenuated by H 2 S or 740 Y-P. ROS production and gp91 phox protein level were increased by HG treatment in HUVECs and this effect can be blocked by the treatment with H 2 S or Y-P 740. Moreover, HG treatment increased the protein levels of pro-inflammatory cytokines, caspase-1 and phosphorylated JNK, which was significantly attenuated by H 2 S or Y-P 740. Importantly, the cytoprotective effect of H 2 S against HG-induced injury was inhibited by LY294002 (an inhibitor of PI3K/Akt/eNOS signaling pathway). Conclusion: The present study demonstrated that exogenous H 2 S protects endothelial cells against HG-induced injuries by activating PI3K/Akt/eNOS pathway. Based on the above findings, we proposed that reduced endogenous H 2 S levels and the subsequent PI3K/Akt/eNOS signaling impairment may be the important pathophysiological mechanism underlying hyperglycemia-induced vascular injuries. Keywords: endothelial cells, hydrogen sulfide, high glucose, injury, PI3K/Akt/eNOS

Hydrogen Sulfide Protects Huvecs Against Hydrogen Peroxide Induced Mitochondrial Dysfunction And Oxidative Stress

Protective Effects Of Hydrogen Sulfide In Hypoxic Human Umbilical Vein Endothelial Cells: A Possible Mitochondria-Dependent Pathway

Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells.

Hydrogen Sulfide Replacement Therapy Protects the Vascular Endothelium in Hyperglycemia by Preserving Mitochondrial Function

Hydrogen Sulfide Inhibits Myocardial Injury Induced by Homocysteine in Rats

Hydrogen Sulfide Attenuates Myocardial Ischemia-Reperfusion Injury by Preservation of Mitochondrial Function

Hydrogen Sulfide Improves Endothelial Dysfunction in Hypertension by Activating Peroxisome Proliferator-Activated Receptor Delta/endothelial Nitric Oxide Synthase Signaling.

Hydrogen Sulfide Attenuates Atherosclerosis in a Partially Ligated Carotid Artery Mouse Model Via Regulating Angiotensin Converting Enzyme 2 Expression.

Hydrogen Sulfide Inhibits Development of Atherosclerosis Through Up-Regulating Protein S-nitrosylation.

Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.

Sirt3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells

Protective effect of hydrogen sulfide on endothelial cells through Sirt1-FoxO1-mediated autophagy

Hydrogen Sulfide Regulates Vascular Endoplasmic Reticulum Stress in Apolipoprotein E Knockout Mice

Hydrogen Sulphide Reduces Hyperhomocysteinaemia-Induced Endothelial ER Stress by Sulfhydrating Protein Disulphide Isomerase to Attenuate Atherosclerosis.

Atherosclerosis And The Hydrogen Sulfide Signaling Pathway - Therapeutic Approaches To Disease Prevention

Hydrogen Sulfide Protects Cardiomyocytes from Hypoxia/reoxygenation-Induced Apoptosis by Preventing GSK-3beta-dependent Opening of Mptp.

Hydrogen sulfide stabilizes atherosclerotic plaques in apolipoprotein E knockout mice.

Hydrogen Sulfide Protects Against High Glucose-Induced Human Umbilical Vein Endothelial Cell Injury Through Activating PI3K/Akt/eNOS Pathway

Hydrogen Sulfide And Endothelial Dysfunction: Relationship With Nitric Oxide

Hydrogen Sulfide Protects Against Apoptosis under Oxidative Stress Through Sirt1 Pathway in H9c2 Cardiomyocytes

Exogenous hydrogen sulfide protects from endothelial cell damage, platelet activation, and neutrophils extracellular traps formation in hyperhomocysteinemia rats.